Gene · 1999
Papers2,176
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,176
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Understanding the role of Pax5 in development of taxane-resistant neuroendocrine like prostate cancers. | Res Sq | 2023 | 38168280 | PubTator, text mining | PubMed |
| Metabolomic Signatures of Treatment Response in Bladder Cancer. | Int J Mol Sci | 2023 | 38139377 | PubTator, text mining | PubMed |
| Ampullary Adenocarcinoma: A Review of the Mutational Landscape and Implications for Treatment. | Cancers (Basel) | 2023 | 38136318 | PubTator, text mining | PubMed |
| The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression. | Cancers (Basel) | 2023 | 38136267 | PubTator, text mining | PubMed |
| Emerging roles of circular RNAs in the invasion and metastasis of head and neck cancer: Possible functions and mechanisms. | Cancer Innov | 2023 | 38125767 | PubTator, text mining | PubMed |
| Expression of Concern: EARLY FLOWERING 3 interactions with PHYTOCHROME B and PHOTOPERIOD1 are critical for the photoperiodic regulation of wheat heading time. | PLoS Genet | 2023 | 38117765 | PubTator, text mining | PubMed |
| Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators. | Cell Genom | 2023 | 38116118 | PubTator, text mining | PubMed |
| Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis. | NPJ Syst Biol Appl | 2023 | 38086828 | PubTator, text mining | PubMed |
| Renal pelvis sarcomatoid carcinoma with renal vein tumor thrombus: A case report and literature review. | World J Clin Cases | 2023 | 38078137 | PubTator, text mining | PubMed |
| SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma. | Nat Commun | 2023 | 38030644 | PubTator, text mining | PubMed |
| Research progress on the biological basis of Traditional Chinese Medicine syndromes of gastrointestinal cancers. | Heliyon | 2023 | 38027682 | PubTator, text mining | PubMed |
| Sulforaphene suppressed cell proliferation and promoted apoptosis of COV362 cells in endometrioid ovarian cancer. | PeerJ | 2023 | 38025760 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancer. | Front Oncol | 2023 | 38023196 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Type VI Secretion System Accessory Protein TagAB-5 Promotes Burkholderia pseudomallei Pathogenicity in Human Microglia. | Biomedicines | 2023 | 38001928 | PubTator, text mining | PubMed |
| A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma. | BMC Complement Med Ther | 2023 | 37990309 | PubTator, text mining | PubMed |
| The HIV-1 capsid serves as a nanoscale reaction vessel for reverse transcription. | bioRxiv | 2023 | 37986899 | PubTator, text mining | PubMed |
| The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic response. | Cancer Med | 2023 | 37986697 | PubTator, text mining | PubMed |
| Genome-wide profiling of transcription factor activity in primary liver cancer using single-cell ATAC sequencing. | Cell Rep | 2023 | 37980571 | PubTator, text mining | PubMed |
| Super-enhancer driven SOX2 promotes tumor formation by chromatin re-organization in nasopharyngeal carcinoma. | EBioMedicine | 2023 | 37967508 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1999/papers?page=11